Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.
Ada Torres
21 July 2026
Subscribe to Updates
Get moves for CERETAS (ASX:CTS) direct to your inbox.
You're on the list!
We'll ping you the moment CERETAS (ASX:CTS) makes a move.
Until then, follow us on socials.
Join 1000's of market focused, signal seeking investors. Unsubscribe anytime. We don't sell your data.